Research Main
관련 학회 일정
Journal Club
무료 이메일 @cell-signaling 계정 만들기

    by Heidi-Dream


대사증후군 및 세포 신호전달 연구실
(Matabolic Syndrome and Cell Signaling Laboratory)



■  Home > Publication

Lab Invest. (2019) doi: 10.1038/s41374 (IF=4.254)
 cell  03-29
Yun UJ, Lee JH, Shim J, Yoon K, Goh SH, Yi EH, Ye SK, Lee JS, Lee H, Park J, Lee IH, Kim YN (2019) Anti-cancer effect of doxorubicin is mediated by downregulation of HMG-Co A reductase via inhibition of EGFR/Src pathway.Lab Invest. , 2019 Jan 30. doi: 10.1038/s41374 (IF=4.254)
 PREV :   Mol Med Rep. (2019) 19(5):3367-3375 (IF=1.922) cell 
 NEXT :   Cell Commun Signal.(2018) 11;16(1):29 (IF=5.324) cell 
Copyright 1999-2024 Zeroboard / skin by GGAMBO



Matabolic Syndrome and Cell Signaling Laboratory in Institute for Cancer Research
Department of Pharmacology, College of Medicine, Chungnam National University
266 Munhwa-ro, Jung-gu, Daejeon, 35015, South Korea
Tel: +82-42-280-6768 Fax: +82-42-585-6627
COPYRIGHT ⓒ 2009 Metabolic Syndrome and Cell Signaling Laboratory, ALL RIGHTS RESERVED.